Marie C Bradley (Marie Bradley)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Decision Making

Coronavirus Disease

Palliative Care

Top Venues

JCO clinical cancer informatics

Open forum infectious diseases

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine C Lerro, Marie C Bradley, Richard A Forshee, Donna R Rivera
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making. JCO clinical cancer informatics 8 (2024)
Catherine C Lerro, Marie C Bradley, Richard A Forshee, Donna R Rivera
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making. JCO clinical cancer informatics 8 (2024)
Catherine C Lerro, Marie C Bradley, Richard A Forshee, Donna R Rivera
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making. JCO clinical cancer informatics 8 (2024)
Sarah E Vititoe, Priya Govil, Aidan Baglivo, Elisha Beebe, Elizabeth M Garry, Nicolle M Gatto, Tamar Lasky, Aloka Chakravarty, Marie C Bradley, Silvia Perez-Vilar, Donna R Rivera, Kenneth Quinto, Andrew Clerman, Anil Rajpal, Vera Frajzyngier
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022. Open forum infectious diseases 10 (7) (2023)
Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca E Ghosh, Stephen Welburn, Anton Pottegard, Robert W Platt, Hana Lee, Marie C Bradley
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. BMJ open 13 (4) (2023)
Elizabeth M Garry, Andrew R Weckstein, Kenneth Quinto, Marie C Bradley, Tamar Lasky, Aloka G Chakravarty, Sandy Leonard, Sarah E Vititoe, Imaani J Easthausen, Jeremy A Rassen, Nicolle M Gatto
Categorization of COVID-19 severity to determine mortality risk. Pharmacoepidemiology and drug safety 31 (7) (2022)
Efe Eworuke, Nicole Haug, Marie C Bradley, Austin Cosgrove, Tancy Zhang, Elizabeth C Dee, Sruthi Adimadhyam, Andrew Petrone, Hana Lee, Tiffany Woodworth, Sengwee Toh
Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States. JNCI cancer spectrum 5 (2) (2021)